4//SEC Filing
Rosenbaum David P. 4
Accession 0001628280-24-040556
CIK 0001437402other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 6:14 PM ET
Size
7.1 KB
Accession
0001628280-24-040556
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Rosenbaum David P.
SVP, Drug Development
Transactions
- Sale
Common Stock
2024-09-13$6.26/sh−5,312$33,254→ 153,616 total(indirect: By Spouse)
Holdings
- 351,510
Common Stock
- 77,592(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Transaction was executed in multiple trades in prices ranging from $6.2601 to $6.265, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote
- [F2]Reflects the adjusted total which includes the purchase of 2,676 shares under the Ardelyx Employee Stock Purchase Plan in August 2024.
- [F3]The shares are directly held by the Reporting Person's wife.
- [F4]The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.
Documents
Issuer
ARDELYX, INC.
CIK 0001437402
Entity typeother
Related Parties
1- filerCIK 0001611311
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 6:14 PM ET
- Size
- 7.1 KB